We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a mostly vaccinated cohort, COVID-19 infections amid ...
The coronavirus has come a long way since 2020. While the days of sanitizing Amazon packages and standing six feet apart may feel like they’re behind us (and they very well may be), the SARS-Co-V-2 ...
Vaccination was shown to lower risk of developing severe COVID-19 in both variants, with the largest difference in risk observed in patients aged 40 to 59 years. Patients infected with the SARS-CoV-2 ...
In a recent study published in the Frontiers in Immunology Journal, a group of researchers examined the immune response and potential cross-protection in hospitalized patients with breakthrough ...
In a recent study posted to the bioRxiv* preprint server, researchers evaluated the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the peripheral nervous system (PNS). Study ...
People who have received two or three doses of an mRNA COVID-19 vaccine are significantly more likely to have milder illnesses if infected with the Delta or Omicron coronavirus variants than those who ...
Please provide your email address to receive an email when new articles are posted on . Prolonged COVID-19 symptoms, including severe fatigue, were more common among patients infected during the ...
Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) can affect many organ systems. However, temporal changes during the coronavirus disease 2019 ...
There was no increased risk of new-onset diabetes post-COVID in a highly vaccinated Asian cohort. Diabetes risk wasn't significantly higher when Delta or Omicron variants were predominant. Boosted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results